Novo Nordisk A/S in 2 stories
The narratives NOVO-B.CO currently appears in, with its side and exposure in each.
Bull side
0 storiesNo bull-side stories for NOVO-B.CO yet.
Bear side
2 stories- The Dollar Loses Its Exceptionalism
NOVO-B.CO in “The Dollar Loses Its Exceptionalism”
AcceleratingExposure: not rated yetFiscal risk and narrowing rate differentials are redirecting capital toward non-dollar assets and punishing currency-sensitive exporters.
Novo Nordisk earns substantial US revenue in dollars while reporting in Danish kroner, creating a translation headwind when the dollar weakens.
- America Imports the World's Drug Prices
NOVO-B.CO in “America Imports the World's Drug Prices”
StableExposure: not rated yetUS reference pricing puts global blockbuster economics—and not just American list prices—under pressure.
Large gaps between US and European obesity-drug prices make Novo Nordisk a prominent reference-pricing target.